Condition
PCOS
Polycystic ovary syndrome (PCOS) and how GLP-1 medications improve insulin sensitivity, hormones, and weight management.
Polycystic ovary syndrome (PCOS) is a hormonal condition affecting 8 to 13 percent of women. Insulin resistance is a core driver. GLP-1 medications like semaglutide can improve insulin sensitivity, support weight loss, and indirectly help restore more regular cycles when combined with lifestyle support.
Education
Understanding the condition
PCOS is a constellation of irregular cycles, elevated androgens, and (often) insulin resistance. Weight management is one of the most powerful levers because it improves insulin sensitivity, which in turn improves the hormonal picture.
Common signs
- Irregular or absent cycles
- Acne or hirsutism
- Weight gain, especially abdominal
- Difficulty conceiving
- Insulin resistance markers
Risk factors
- Family history
- Insulin resistance
- Visceral adiposity
This page is educational and is not a diagnosis. A licensed provider evaluates your individual health history before any treatment decision.
Treatment options
Protocols that address it
Prescribed only if a licensed provider determines treatment is appropriate for you.
PCOS, addressed.
Share your health history online. A licensed provider will determine whether treatment is appropriate for you.
Takes ~5 min · 100% online · No insurance needed